GLP-1 drugs, originally developed to treat diabetes and now widely used for obesity, are reshaping healthcare in the US.
Source: Al Jazeera — This article was automatically imported from the source. Read full article at original source →
GLP-1s are changing US healthcare, should everyone be on them?
Originally published by
Al Jazeera
aljazeera.com
Visit original article
